|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 35/28 | |
| A61P 37/06 | |||
| C12N 5/077 | |||
| C12N 5/0789 | |||
| A61K 38/21 | |||
| C12N 5/0775 |
| (11) | Number of the document | 2714057 |
| (13) | Kind of document | T |
| (96) | European patent application number | 12792873.7 |
| Date of filing the European patent application | 2012-06-04 | |
| (97) | Date of publication of the European application | 2014-04-09 |
| (45) | Date of publication and mention of the grant of the patent | 2019-11-06 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/AU2012/000626 |
| Date | 2012-06-04 |
| (87) | Number | WO 2012/162754 |
| Date | 2012-12-06 |
| (30) | Number | Date | Country code |
| 201161493073 P | 2011-06-03 | US |
| (72) |
BERNARD, Claude, AU
|
| (73) |
Mesoblast, Inc.,
505 Fifth Avenue Level 3, New York, NY 10017,
US
|
| (54) | METHODS OF TREATING OR PREVENTING NEUROLOGICAL DISEASES |
| METHODS OF TREATING OR PREVENTING NEUROLOGICAL DISEASES |